Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Haematology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 5 · 71.4%High 2 · 28.6%

All‐cause mortality · participants with haematological malignancies

BMT showed no clear difference in mortality compared with PBSCT (high certainty).

1 finding from 1 review

Relapse, progression or death (calculated instead of PFS) · participants with haematological malignancies

BMT showed no clear difference in progress, relapse or death compared with PBSCT (moderate certainty).

1 finding from 1 review

Non relapse or transplant related mortality · participants with haematological malignancies

BMT showed no clear difference in non relapse or transplant related mortality compared with PBSCT (high certainty).

1 finding from 1 review

Chronic GVHD (extensive) · participants with haematological malignancies

BMT probably leads to lower extensive chronic GvHD compared with PBSCT (moderate certainty).

1 finding from 1 review

Acute GvHD III to IV · participants with haematological malignancies

BMT showed no clear difference in acute GvHD III to IV compared with PBSCT (moderate certainty).

1 finding from 1 review

Chronic GvHD overall · participants with haematological malignancies

BMT probably leads to lower chronic GvHD overall compared with PBSCT (moderate certainty).

1 finding from 1 review

Acute GVHD II to IV · participants with haematological malignancies

BMT showed no clear difference in acute GvHD II to IV compared with PBSCT (moderate certainty).

1 finding from 1 review